Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

28811 - 28820 of 49233 results found

Off-Label Use of Baricitinib in Dermatology

Date
Wednesday, August 09, 2023 - 4:00 AM
Description
The current US Food and Drug Administration (FDA) indications for baricitinib include alopecia areata, rheumatoid arthritis, and COVID-19. However, increasing evidence indicates that baricitinib is effective in treating a variety of dermatological

Characterizing long-COVID brain fog: a retrospective cohort study

Date
Wednesday, August 09, 2023 - 4:00 AM
Description
CONCLUSIONS: Neurocognitive impairment represents a severe phenotype of PCC, associated with unique risk factors, aberrancy in immune response and a delayed recovery trajectory. Those with risk factors for neurocognitive impairment can be identified